ENTITY
Rohto Pharmaceutical

Rohto Pharmaceutical (4527 JP)

39
Analysis
Health Care • Japan
ROHTO PHARMACEUTICAL CO., LTD. manufactures and markets pharmaceuticals and cosmetics products. The Company's products include eyewash, bath soaps, gastrointestinal medicine, and hand cream. Rohto Pharmaceutical also has a license agreement with its subsidiary, Mentholatum (US) to sell their brand products. The Company also manufactures contact lenses and health foods.
more
bearish•FineToday Holdings
•24 Nov 2024 20:46

FineToday Holdings (289A JP) IPO: The Bear Case

The bear case rests on the weak 3Q24 revenue performance, mid-tier revenue growth, leveraged balance sheet, share overhang and pre-IPO dividend.

Logo
784 Views
Share
bullish•FineToday Holdings
•21 Nov 2024 15:19

FineToday Holdings (289A JP) IPO: The Bull Case

The bull case rests on return to revenue growth, three-pronged growth strategy, top-quartile profitability and top-tier FCF generation.

Logo
690 Views
Share
bullish•Fancl Corp
•13 Aug 2024 15:42

Fancl (4921 JP): Kirin (2503 JP) Relents and Bumps to JPY2,800

MY.Alpha has increased its shareholding from 10.3m (8.51% ownership ratio) to 11.6m (9.58%) primarily due to purchasing 1.1m shares at JPY2,794 on...

Logo
673 Views
Share
bullish•Fancl Corp
•29 Jul 2024 13:28

Fancl (4921 JP): Evaluating the Potential of Kirin (2503 JP) Offer Bump

Kirin has extended the tender offer period from 29 July to 13 August (40 business days). Kirin believes the JPY2,690 offer sufficiently reflects...

Logo
919 Views
Share
•17 Jun 2024 16:04

L’Occitane (973 HK): Share Alternative a Crucial Step Towards the Offer Being Declared Unconditional

An attractive offer and the share alternative facilitate meeting the 90% minimum acceptance condition. This looks like a done deal. At the current...

Logo
420 Views
Share
x